← FDA Drug Approvals (Drugs@FDA)

CONEXXENCE

BLA · Biologics License Application · Sponsor: FRESENIUS KABI USA LLC · Approved 2025-03-25

Drug application

FDA Application #

BLA761398

Application type

Biologics License Application

Brand name

CONEXXENCE

Generic name

DENOSUMAB

Active ingredients

DENOSUMAB-BNHT

Dosage form

INJECTION

Route

—

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA LLC

Manufacturer

Fresenius Kabi USA, LLC

First approval

2025-03-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown